NASDAQ:ROIV
Citigroup analysts initates a Buy rating for Roivant Sciences Ltd (ROIV)
In a filing, Roivant Sciences Ltd revealed its Officer Venker Eric acquired Company’s shares for reported $4.17 million on Dec ...
Keeping an Eye on Roivant Sciences Ltd (ROIV) After Insider Trading Activity
Roivant Sciences Ltd’s recent filing unveils that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $26.3 million on ...
Investing in Roivant Sciences Ltd (ROIV) Is Getting More Attractive
Roivant Sciences Ltd’s recently made public that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $26.3 million on ...
ROIV price target predicted to rise nearly 22.5 in 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Insider Selling: Venker Eric, Roivant Sciences Ltd [ROIV] President & Immunovant CEO divested 200,000 shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Positive sentiment towards ROIV reflected in decline in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
ROIV shares expected to outperform in the next 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
